ONEOK, Inc. (NYSE: OKE) (“ONEOK”) and EnLink Midstream, LLC (NYSE: ENLC) (“EnLink”) today announced that the two leading independent proxy advisory firms, Institutional Shareholder Services Inc. (ISS) and Glass Lewis & Co. (Glass Lewis), have recommended that EnLink unitholders vote in favor of ONEOK's pending acquisition of the remaining publicly held common units of EnLink […]

Rollins, Inc. (NYSE:ROL), a premier global consumer and commercial servicescompany announced that the Board of Directors declared a regular quarterly cash dividend on its common stock of $0.165 per share payable March 10, 2025 to shareholders of record at the close of business on February 25, 2025. This represents an increase of 10 percent from

(NASDAQ:HBNC), MICHIGAN CITY, Ind., Jan. 22, 2025 (GLOBE NEWSWIRE) — (NASDAQ GS: HBNC) – Horizon Bancorp, Inc. (“Horizon” or the “Company”), the parent company of Horizon Bank (the “Bank”), announced its unaudited financial results for the three months and year ended December 31, 2024. “We are very pleased with Horizon's fourth quarter results, which displayed

(TSX:BTO),(NYSE MKT:BTG),(Namibian:B2G), VANCOUVER, British Columbia, Jan. 22, 2025 (GLOBE NEWSWIRE) — B2Gold Corp. (TSX: BTO, NYSE AMERICAN: BTG, NSX: B2G) (“B2Gold” or the “Company”) announces that it is offering convertible senior unsecured notes due 2030 (the “Notes”) in an aggregate principal amount of US$350 million (the “Offering”). The Company expects to grant the initial purchasers

(NASDAQ:TLSA), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a fully human, anti-CD3 monoclonal antibody, today announced the discovery of new immune biomarkers in patients with non-active secondary progressive multiple sclerosis

(NASDAQ:CDMO),(NASDAQ:CDMOP), TUSTIN, Calif., Jan. 22, 2025 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ: CDMO) (“Avid” or the “Company”), a dedicated biologics contract development and manufacturing organization (“CDMO”) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced that it has mailed a letter to stockholders

(NASDAQ:ADPT), SEATTLE, Jan. 22, 2025 (GLOBE NEWSWIRE) — Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, today announced it will report financial results for the fourth quarter and full year 2024 after market close

(NASDAQ:AVPT), JERSEY CITY, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) — AvePoint (NASDAQ: AVPT), the global leader in data security, governance, and resilience, will report its fourth quarter and full year 2024 financial results after the US financial markets close on Thursday, February 27, 2025. The Company will also host an Investor Day at 8:30am ET

(NASDAQ:CBUS), SAN DIEGO, Jan. 22, 2025 (GLOBE NEWSWIRE) — Cibus, Inc. (Nasdaq: CBUS) (the “Company”), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating

(NASDAQ:VECO), PLAINVIEW, N.Y., Jan. 22, 2025 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its fourth quarter 2024 financial results after the market closes on Wednesday, February 12, 2025. The company will host a conference call to review these results starting at 5:00 PM ET that day. To join the call, dial